Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Launched in October 2016, Big Drop Brewing is a world-leading alcohol-free craft brewer. The company brews beer naturally by using specialist brewing methods to ensure the alcohol never exceeds 0.5%. The beer is not only Alcohol-Free, but is also gluten-free and many are low in sugar. Their award-winning lager is vegan-friendly. The company does not have a brewery of its own but partners with reputable breweries around the world, who share their brewing values to produce the beer. Big Drop Brewing has secured private funding already and meaningful distribution in the UK and 12 overseas markets. They have also secured off-trade listings in Tesco, Morrisons and Ocado. Half of the investment will be used for Sales & Marketing, 30% for new branding launch and related marketing, 10% for production costs and the remaining 10% for product development.
days to go:
Expired
investment:
£617,566
Opportunity Network is a digital network that provides equal growth opportunities to Chief Executive Officers (CEO). The portal's algorithm vets prospective users, allows them to buy, sell, raise or invest in an asset, gives them the option to choose the industry they wish to do business in, and then post their requirement for the same. The user can then select the best deal for their business from a list of responses and scale profitably. The company's platform connects 32,000+ qualified CEOs in 130+ countries to $295 billion worth of commercial, financial, and mergers and acquisitions (M&A) deals. 86% of the deals on the portal find at least 1 counterpart in 48 hours. Opportunity Network aims to reach full scale by the end of 2020 and find 10 counterparts for 95% of the deals in 1 hour. The company has also been featured in publications such as Forbes, CNBC, Financial Times, and The Economist. It will use the investment to scale its business across various verticals.
days to go:
Expired
investment:
£962,500
Run3D is a biotechnology company that has developed a 3D gait analysis system with the aim to help people identify injuries, deliver better performance, and make better running decisions. 3D gait analysis involves using infrared cameras to track positions of small reflective markers attached to a person in motion, capturing measurable data to help quantify a person's risk of injury, biomechanical efficiency, performance, footwear, and recommend proper diagnosis where necessary. The company plans to use the investment to grow its business.
days to go:
Expired
investment:
Withheld
Swoopos is a mobile point of sale system, which brings together innovative software and hardware, cloud reporting and data analytics, mobile and ecommerce ordering and beacon marketing technology for retail, hospitality and stadiums. Swoops have already built long term relationships with leading brands and are now looking to expand throughout the UK and beyond.
days to go:
Expired
investment:
£64,480
